Stocks
Axsome Therapeutics (AXSM) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -148.5% | -56.5% | -40.7% | -50.5% | -26.6% | -26.4% | ||
| Changes by years, y/y, % | -93pp | +92pp | +16pp | -10pp | +24pp | -13.6% | |||
Axsome Therapeutics. ROA, %
Axsome Therapeutics. ROA, changes, pp
Axsome Therapeutics (AXSM) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | -46.6% | -38.6% | -34.3% | -26.6% | -26.4% | -26.4% | |
| Changes by years, y/y, % | +8pp | +18pp | +21pp | +24pp | +20pp | |||
| Changes by quarters, q/q, % | +4pp | +8pp | +4pp | +8pp | +0pp | |||
